(Rac)-EC5026 (Synonyms: (Rac)-BPN-19186) |
| Catalog No.GC62743 |
(Rac)-EC5026((Rac)-BPN-19186)은 특허 WO2019156991A1(39페이지)에서 추출된 가용성 에폭사이드 가수분해효소(sEH)의 강력한 피페리딘 억제제이며 0.06 nM의 Ki를 갖는다.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1809885-55-9
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
(Rac)-EC5026 ((Rac)-BPN-19186) is a potent piperidine inhibitor of soluble epoxide hydrolase (sEH) extracted from patent WO2019156991A1, page 39, has a Ki of 0.06 nM. (Rac)-EC5026 can be used for the research of Parkinson’s disease and dementia with Lewy Bodies (DLB)[1].
(Rac)-EC5026 inhibits soluble epoxide hydrolase (sEH), with a Ki of 0.06 nM[1].
[1]. Hammock BD, et, al. Methods of inhibiting formation of alpha synuclein aggregates. WO2019156991A1.
Average Rating: 5 (Based on Reviews and 23 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *